4//SEC Filing
Zdanowski Michael 4
Accession 0000899243-22-030933
CIK 0001827506other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:31 PM ET
Size
5.1 KB
Accession
0000899243-22-030933
Insider Transaction Report
Form 4
Zdanowski Michael
Chief Technology Officer
Transactions
- Award
Common Stock
2022-09-10+120,000→ 121,470 total
Footnotes (1)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest as to 50% of the underlying shares on July 1, 2023 and the remaining 50% on July 1, 2024, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001845662
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:31 PM ET
- Size
- 5.1 KB